Pharma Mar SA - Strategy, SWOT and Corporate Finance Report

Pharma Mar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent indicated for the treatment of advanced or metastatic soft tissue sarcoma and relapsed ovarian cancer. Pharma Mar’s developmental pipeline includes Aplidin (plitidepsin) for multiple myeloma and T-cell lymphoma; Zepsyre (lurbinectedin) for small cell lung cancer; and PM184 for advanced breast cancer and solid tumors. It also develops RNAi candidates for the treatment of retina diseases. The company has subsidiaries in Germany, Italy, France, Switzerland, the UK, Belgium and the US. Pharma Mar is headquartered in Madrid, Spain.

Scope

  • Detailed information on Pharma Mar SA required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Pharma Mar SA in the form of a SWOT analysis
  • An in-depth view of the business model of Pharma Mar SA including a breakdown and examination of key business segments
  • News about Pharma Mar SA, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Pharma Mar SA and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Pharma Mar SA as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Pharma Mar SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Ability Pharmaceuticals SL

Ariad Pharmaceuticals (Spain) SL

GP Pharm SA

Traslational Cancer Drugs Pharma SL

CTI BioPharma Corp

Oryzon Genomics SA

Ability Pharmaceuticals SL

Ariad Pharmaceuticals (Spain) SL

GP Pharm SA

Traslational Cancer Drugs Pharma SL

CTI BioPharma Corp

Oryzon Genomics SA

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Pharma Mar SA - Key Facts

Pharma ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Pharma Mar SA - Key Facts

Pharma Mar SA - Key Employees

Pharma Mar SA - Key Employee Biographies

Pharma Mar SA - Major Products and Services

Pharma Mar SA - History

Pharma Mar SA - Company Statement

Pharma Mar SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Pharma Mar SA - Business Description

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Consumer Chemicals

Overview

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Rest of the European Union

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: Spain

Performance

Geographical Segment: the US

Performance

R&D Overview

Pharma Mar SA - SWOT Analysis

SWOT Analysis - Overview

Pharma Mar SA - Strengths

Pharma Mar SA - Weaknesses

Pharma Mar SA - Opportunities

Pharma Mar SA - Threats

Pharma Mar SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Pharma Mar SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 29, 2019: PharmaMar announces results for the first half of 2019

Jul 29, 2019: Pharma Mar announces change in composition of-the board of directors

Apr 26, 2019: PharmaMar Group reports results for the first quarter of 2019

Apr 09, 2019: PharmaMar announces its new immunotherapy research program

Mar 26, 2019: PharmaMar to attend the China Healthcare Investment Conference (CHIC)

Mar 21, 2019: PharmaMar: Soft Tissue Sarcoma requires a multidisciplinary approach to reduce patient relapses and improve patient survival

Feb 28, 2019: PharmaMar Group reports 2018 results

Oct 30, 2018: PharmaMar reports net profit of €5 million at the end of the third quarter of 2018

Oct 01, 2018: PharmaMar names Ali Zeaiter as new Director of Clinical Development

Aug 13, 2018: Immedica – a platform for pan-European niche specialty pharma launch, commercialization and distribution services

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Pharma Mar SA, Key Facts

Pharma Mar SA, Key Employees

Pharma Mar SA, Key Employee Biographies

Pharma Mar SA, Major Products and ...

List of Tables

Pharma Mar SA, Key Facts

Pharma Mar SA, Key Employees

Pharma Mar SA, Key Employee Biographies

Pharma Mar SA, Major Products and Services

Pharma Mar SA, History

Pharma Mar SA, Subsidiaries

Pharma Mar SA, Key Competitors

Pharma Mar SA, Ratios based on current share price

Pharma Mar SA, Annual Ratios

Pharma Mar SA, Annual Ratios (Cont...1)

Pharma Mar SA, Annual Ratios (Cont...2)

Pharma Mar SA, Interim Ratios

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Pharma Mar SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Pharma Mar SA, Performance Chart (2014 - 2018)

Pharma Mar SA, Ratio Charts

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Pharma Mar SA, Performance Chart (2014 - 2018)

Pharma Mar SA, Ratio Charts

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Pharma Mar SA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports